Doctor profile · Federal record
Dr. Daniel Wallace, M.D.
Rheumatology Physician · Beverly Hills, CA
- NPI 1982608717
- MIPS 76.8 / 100 · 2023
- 21 yrs on file
- Male
- Solo practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
8750 Wilshire Blvd Ste 210
Beverly Hills, CA 902112703
(310) 652-0920
fax (310) 652-2482 - Additional location
-
8730 Alden Dr
Los Angeles, CA 90048
(310) 423-3870
fax (310) 423-0429 - Mailing address
-
Po Box 18736
Beverly Hills, CA 902094736
Credentials & registration
- NPI registered
- June 2005 — 21 yrs on file
- Profile last updated
- March 22, 2022
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- California #G30533
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1982608717. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
118,539
Distinct HCPCS
10
Medicare allowed
$1,495,563
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 39,200 | 14 | $5 | |
J3262 |
Injection, tocilizumab, 1 mg | 38,772 | 16 | $6 | |
J1306 |
Injection, inclisiran, 1 mg | 12,632 | 29 | $12 | |
J0897 |
Injection, denosumab, 1 mg | 6,540 | 81 | $23 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 6,081 | 12 | $13 | |
J0490 |
Injection, belimumab, 10 mg | 5,623 | 11 | $49 | |
J0517 |
Injection, benralizumab, 1 mg | 1,380 | 12 | $167 | |
96372 |
Injection of drug or substance under skin or into muscle | 768 | 212 | $16 | |
86160 |
Measurement of complement (immune system proteins), antigen, | 589 | 240 | $12 | |
82784 |
Gammaglobulin (immune system protein) measurement | 484 | 151 | $9 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 1,781. This provider delivers 67× the peer median.Open Payments
Industry payments received
All-time total
$16,808
Transactions
112
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $8,073.45 | |
| GlaxoSmithKline, LLC. | 4 | $3,980.08 | |
| Janssen Research & Development, LLC | 2 | $2,070.00 | |
| ABBVIE INC. | 45 | $1,131.30 | |
| Novartis Pharmaceuticals Corporation | 21 | $507.87 | |
| Aurinia Pharma U.S., Inc. | 1 | $275.00 | |
| Amgen Inc. | 7 | $192.12 | |
| UCB, Inc. | 3 | $128.86 | |
| PFIZER INC. | 4 | $115.87 | |
| Kiniksa Pharmaceuticals International, plc | 3 | $77.01 | |
| Genentech USA, Inc. | 3 | $63.30 | |
| ANI Pharmaceuticals, Inc. | 2 | $51.59 | |
| Radius Health, Inc. | 2 | $49.99 | |
| Lilly USA, LLC | 2 | $47.35 | |
| SOBI, INC | 1 | $22.57 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
964
Patients
219
Total drug cost
$360,105
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 220 | 55 | $9,902 |
| Prednisone | Generic | 132 | 40 | $1,126 |
| Methotrexate (Methotrexate Sodium) | Brand | 110 | 26 | $3,756 |
| Levothyroxine Sodium | Generic | 70 | 17 | $1,153 |
| Leflunomide | Generic | 61 | 22 | $4,455 |
| Gabapentin | Generic | 56 | 16 | $870 |
| Celecoxib | Generic | 55 | 18 | $3,396 |
| Alendronate Sodium | Generic | 39 | 12 | $496 |
| Meloxicam | Generic | 39 | 13 | $238 |
| Duloxetine Hcl | Generic | 37 | 0 | $1,039 |
Frequently asked questions
What is Dr. Daniel Wallace's medical specialty?
Dr. Daniel Wallace practices Rheumatology Physician in Beverly Hills, CA.
Where does Dr. Daniel Wallace practice?
Dr. Daniel Wallace practices at 8750 Wilshire Blvd Ste 210, Beverly Hills, CA 902112703. Office phone: 3106520920.
What is Dr. Daniel Wallace's NPI?
Dr. Daniel Wallace's National Provider Identifier (NPI) is 1982608717, issued by NPPES.
What procedures does Dr. Daniel Wallace commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, inclisiran, 1 mg (HCPCS J1306). Source: CMS Medicare Physician & Other Practitioners file.